About Frontage Laboratories
Frontage Laboratories is a publicly listed company based in Exton (United States) founded in 2001, and was acquired by Tigermed in May 2014. It operates as an early drug development services are provided for pharma firms. Frontage Laboratories has raised $10.24 million across 1 funding round from investors including Tigermed and Baird Capital. The company has 1,560 employees. Frontage Laboratories has completed 7 acquisitions, including Acme Bioscience, BRI Biopharmaceutical Research and BioTranex. Its website frontagelab.com draws about 10 thousand monthly visits. Frontage Laboratories offers products and services including Drug Discovery Services, Drug Development Services, and Laboratory Testing Services. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its legal entity is Frontage Laboratories, Inc. Its competitors include Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Precision for Medicine and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Frontage Laboratories was established in 2001 in Exton, United States, operating as a contract research organization in the pharmaceutical and biotechnology sectors. Early-phase drug development services are delivered, encompassing bioanalytical laboratory operations, discovery-stage activities, preclinical metabolism and pharmacokinetics studies, phase IIIa clinical trials, and product development support. Organic synthesis, formulation development, GMP analytical testing, and clinical trial material manufacturing under GMP standards are also conducted for diverse drug candidates.
- Annual Revenue$256.93 M (USD)0.61as on Dec 31, 2025
- Net Profit$6.8 M (USD)758.02as on Dec 31, 2025
- EBITDA$51.03 M (USD)11.59as on Dec 31, 2025
- Total Equity Funding$10.24M (USD)
in 1 rounds
- Latest Funding Round$10.24M (USD), Series A
Apr 2008
- InvestorsTigermed
& 1 more
- Employee Count1,560
- Investments & AcquisitionsAcme Bioscience
& 6 more
- Acquired byTigermed
(May 2014)
Products & Services of Frontage Laboratories
Frontage Laboratories offers a comprehensive portfolio of products and services, including Drug Discovery Services, Drug Development Services, and Laboratory Testing Services.
Provides end-to-end chemistry and biology for drug candidates
Supports preclinical and clinical trial processes
Offers bioanalytical and analytical testing for pharmaceuticals
Apps and channels of Frontage Laboratories
its YouTube channel Frontage Laboratories, Inc has 78 subscribers.
Funding Insights of Frontage Laboratories
Frontage Laboratories has successfully raised a total of $10.24M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.24 million completed in April 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.24M
- Total Rounds 1
- Last Round Series A — $10.24M
- First Round $10.24M
(Apr 2008)
- Investors Count 1
All 1 funding rounds of Frontage Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2008 | $10.24M | Series A | – | Baird Capital | – |
2 investors in total: 2 institutional.
Investors in Frontage Laboratories
Frontage Laboratories has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Tigermed and Baird Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity and venture capital investments in B2B Tech & Services companies. | – | bairdcapital.com | - | |
Drug development and preclinical services are provided by Tigermed. | 2004 | tigermedgrp.com | Hangzhou, China |
Investor details for Frontage Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Frontage Laboratories
161 people are tracked at Frontage Laboratories (63 in leadership, 1 in board & advisors, 97 in team); the tracked headcount is 1,560.
| Name | Role | Group |
|---|---|---|
Tianyi Zhang | Vp, Bioanalytical/dmpk (china) | Leadership |
Shauna Casimir | Senior Director Of Quality Assurance | Leadership |
Krupal Morker | Director, CMC Product Development | Leadership |
Yining Qi | President, Frontage's China Operations | Leadership |
Huiming Tu | Sr. Director Of LIS And Data Management | Leadership |
Farah Denahan | Senior Vice President, Site Head | Leadership |
Koppara Samuel | Executive Director | Leadership |
Richard Fischetti | VP & General Counsel | Leadership |
Xiaoyun Niu | Associate Director, Contract And Project Management | Leadership |
Chaoyang Dai | Sr. Director Of Business Development | Leadership |
Mike Beach | Associate Director | Leadership |
Guoxiao Xu | Associate Director Of PRD | Leadership |
Sudendra Rao Gphr (Suden) | Senior VP HR | Leadership |
Lili Liao | Director | Leadership |
Huachun Chen | Director, Business Development | Leadership |
Raj Yadwad | Vice President, Operations | Leadership |
Min Wang | Chief Operating Officer | Leadership |
Azhar K. | VP Strategic Business Development | Leadership |
Lian Chen | Vice President Bioanalytical Services | Leadership |
Tao Xu | Director | Leadership |
141 more people are available in the full profile.
Complete people profiles for Frontage Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Frontage Laboratories
Frontage Laboratories is a publicly listed company on the HKEX with ticker symbol 1521 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 May 2019
- Listed onHKG: 1521
- Listed entityFrontage Holdings Corp.
- Exchange sectorHealth technology
- ISINKYG3679P1019
- Share price1.14 HKD (+3.18% on the day) · 2026-10-14
- Market capitalisation2,246,282,361.00 HKD
- Price to earnings27.8
- EPS (diluted, trailing year)0.04 HKD
- Volume (last session)186,000
Financials of Frontage Laboratories
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2.00B HKD | 53.0M HKD | 397.2M HKD |
| 2024 | 1.99B HKD | 6.2M HKD | 355.9M HKD |
| 2023 | 2.03B HKD | 84.6M HKD | 432.4M HKD |
| 2022 | 1.96B HKD | 201.5M HKD | 492.9M HKD |
| 2021 | 1.43B HKD | 143.2M HKD | 382.5M HKD |
Detailed financial statements for Frontage Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Frontage Laboratories
Frontage Laboratories has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Acme Bioscience, BRI Biopharmaceutical Research and BioTranex.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services | nucro-technics.com | Scarborough, Canada | 1970 | Aug 2023 | •••• | |
Provider of a wide range of genomics services | oceanridgebio.com | Deerfield Beach, United States | 2006 | Apr 2021 | •••• | |
Medicinal and synthetic chemistry services | acmeca.com | Palo Alto, United States | 2001 | Jul 2020 | •••• | |
DMPK and analytical services are offered via hepatocyte-based platforms. | biotranex.com | Monmouth Junction, United States | 2009 | Apr 2020 | •••• | |
Analytical and bioanalytical services for drug development are provided. | bripharm.com | Vancouver, Canada | 1991 | Dec 2019 | •••• | |
ADME and DMPK services are provided through mass spectrometry techniques. | rmilaboratories.com | North Wales, United States | 2009 | Nov 2019 | •••• | |
CRO supporting pharmaceutical, agricultural, chemical and veterinary industries | concordbio.com | Concord, United States | 1986 | Apr 2018 | •••• |
Complete acquisition details for Frontage Laboratories
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Frontage Laboratories
11 dated milestones of Frontage Laboratories across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Frontage Laboratories is founded.
- Funding First funding round of $10.2M.
- Exit Acquired by Tigermed.
- Acquisition Acquires Concord Biosciences.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires RMI Laboratories.
- Acquisition Acquires BRI Biopharmaceutical Research.
- Acquisition Acquires BioTranex.
- Acquisition Acquires Acme Bioscience.
- Acquisition Acquires Ocean Ridge Biosciences.
- Acquisition Acquires Nucro-Technics.
Competitors of Frontage Laboratories
Frontage Laboratories has 9 listed competitors in our database, 6 of them funded. They include Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Precision for Medicine, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | – | 21,400 | Provider of drug discovery and preclinical development services | |
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | – | 9,321 | Provider of laboratory tests for physicians | |
| precisionmedicinegrp.com | 2012 | Bethesda, United States | $257.21M | 2,151 | Provider of clinical research, development, and commercialization services for life sciences | |
| precisionformedicine.com | 2013 | Bethesda, United States | $150M | – | Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices | |
| canopybiosciences.com | 2016 | St. Louis, United States | $4.48M | – | Cell line engineering services are offered via CRISPR-Cas9 technology. | |
| taimei.com | 2013 | Pleasanton, United States | $193.73M | – | A digital intelligence platform is focused on life sciences activities. | |
| scantox.com | 1977 | Lille Skensved, Denmark | – | 30 | Laboratory focused on providing pharmacology, toxicology, and histopathology services | |
| tenpointtherapeutics.com | 2020 | Cambridge, United Kingdom | $70M | – | Engineered cell-based therapeutics are developed to restore vision. |
Detailed competitors of Frontage Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Frontage Laboratories
The website of Frontage Laboratories (frontagelab.com) receives about 10.4K visits a month.
- Monthly visits10.4K
▲ 29.4% vs previous month
Websites whose visitors overlap most with Frontage Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| waters.com | 100% | 416.8K | #124,184 | View details | |
| perkinelmer.com | 99% | 164.5K | #258,286 | View details | |
chem.agilent.com | chem.agilent.com | 99% | – | – | – |
integratedbiomolecule.com | integratedbiomolecule.com | 94% | – | – | – |
| bioanalyte.com | 94% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Frontage Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Frontage Laboratories (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Frontage Laboratories
Complete news archive for Frontage Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Frontage Laboratories
Frontage Laboratories was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Frontage Laboratories is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Frontage Laboratories is a funded company, having raised a total of $10.24M across 1 funding round to date. The company's 1st funding round was a Series A of $10.24M, raised on Apr 2008.
Frontage Laboratories has 1,560 employees.
Annual revenue of Frontage Laboratories is $256.93M as on Dec 31, 2025.
Frontage Laboratories was established in 2001 in Exton, United States, operating as a contract research organization in the pharmaceutical and biotechnology sectors. Early-phase drug development services are delivered, encompassing bioanalytical laboratory operations, discovery-stage activities, preclinical metabolism and pharmacokinetics studies, phase IIIa clinical trials, and product development support. Organic synthesis, formulation development, GMP analytical testing, and clinical trial material manufacturing under GMP standards are also conducted for diverse drug candidates.
Frontage Laboratories's top competitors include LabCorp, Charles River Laboratories and Cytel.
Frontage Laboratories offers Drug Discovery Services, Drug Development Services, and Laboratory Testing Services.
Yes, Frontage Laboratories is publicly traded on HKEX under the ticker symbol 1521.
Frontage Laboratories has made 7 acquisitions, including Acme Bioscience, BRI Biopharmaceutical Research, and BioTranex.
Frontage Laboratories has 2 investors. Key investors include Tigermed, and Baird Capital.
Frontage Laboratories operates through Frontage Laboratories, Inc.